Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Infective endocarditis after TAVR tied to mortality, stroke risks

24 Jun 2020

Infective endocarditis after transcatheter aortic valve replacement (TAVR) is commonly caused by Enterococcus species and usually occurs during the early period, reveals a study. It is also associated with significant risks of mortality and stroke.

A total of 7,203 patients underwent TAVR at 15 hospitals in Switzerland during the observational period. Of these, 149 patients had endocarditis during follow-up of 14,832 patient-years. Peri-procedural endocarditis after TAVR had the highest incidence at 2.59 events per 100 person-years, followed by delayed-early and late endocarditis with 0.71 and 0.40 events per 100 person-years, respectively.

The most frequently isolated microorganism among patients with early endocarditis was Enterococcus species (30.1 percent). Among those with peri-procedural endocarditis, 47.9 percent had a pathogen that was not susceptible to the peri-procedural antibiotic prophylaxis.

The following factors correlated independently with endocarditis: younger age (subhazard ratio [SHR], 0.969, 95 percent confidence interval [CI], 0.944–0.994), male sex (SHR, 1.989, 95 percent CI, 1.403–2.818), lack of predilatation (SHR, 1.485, 95 percent CI, 1.065–2.069), and treatment in a catheterization laboratory as opposed to hybrid operating room (SHR, 1.648, 95 percent CI, 1.187–2.287).

Of note, the risks of mortality (HR, 6.55, 95 percent CI, 4.44–9.67) and stroke (HR, 4.03, 95 percent CI, 1.54–10.52) were increased in patients with endocarditis, according to the results of a case-control matched analysis.

This study included consecutive patients from the SwissTAVI Registry between February 2011 and July 2018. Infective endocarditis was classified into early (peri-procedural [<100 days] and delayed-early [100 days to 1 year]) and late (>1 year) endocarditis. The authors assessed clinical events according to the Valve Academic Research Consortium-2 endpoint definitions.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.